AD-214

DB18412InvestigationalProtein Based Therapies

AD-214: Overview.

Mechanism: Pharmacologically active on C-X-C chemokine receptor type 4
Curator reviewed
Also known as: Fc-fusion protein comprised of an anti-CXCR4 i-body tethered at its C-terminus to constant domains 2 and 3 of the Fc region of a mutated human IgG1
Code names: AD-214

Resolves to

Compound

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with AD-214, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.